PECAM1 and chronic kidney disease: In vivo, delivery of adeno-associated virus (AAV)–miR-29a-5p or treatment with DAPT significantly blunted EndMT, restored CD31 expression, reduced NICD/Hes1 levels, and attenuated calcium–phosphate deposition in CKD rat aortic valves.